Caspase-3(-like) proteases play important roles in controlling mammalian apoptosis. However, the downstream events from the caspase-3(-like) protease activation to death of cells are still unclear. Previously, we reported that hydrogen peroxide (H 2 O 2 ) was generated by the activation of caspase-3(-like) proteases in the process of tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma Ms-1 cells. In the present study, we examined whether generation of H 2 O 2 is a critical event for the apoptotic pathway downstream of caspase-3(-like) protease activation by various anticancer drugs. Anticancer drugs such as camptothecin, vinblastine, inostamycin, and adriamycin induced activation of caspase-3(-like) proteases and apoptosis. Generation of H 2 O 2 was commonly detected after treatment with each of the four anticancer drugs, and scavenging of H 2 O 2 caused cells to fail to undergo apoptosis. Moreover, anticancer drug-induced H 2 O 2 production was inhibited not only by an inhibitor of caspase-3(-like) proteases but also by diphenyleneiodonium chloride, an inhibitor of flavonoid-containing enzymes such as NADPH oxidase. However, activation of caspase-3(-like) proteases was not inhibited by diphenyleneiodonium chloride. These findings suggest that activation of caspase-3(-like) proteases by various anticancer drugs causes generation of H 2 O 2 presumably through the activation of NADPH oxidase, thereby inducing apoptosis.
Apoptosis is a fundamental biochemical cell death pathway for normal tissue homeostasis, cellular differentiation, and development within a multicellular organism (for review, see Refs. [1] [2] [3] [4] . A family of interleukin 1␤-converting enzyme (ICE) 1 cysteine proteases (now called caspases) are clearly activated in apoptosis and appear to be required for certain aspects of apoptosis. Among them, caspase-3 (CPP32/Yama/ apopain)-like proteases are responsible for the cleavage of some substrates at the onset of apoptosis. With the developing understanding of mechanisms regulating apoptosis, it is becoming increasingly clear that a number of cytotoxic stimuli, including chemotherapeutic agents, operate through similar mechanisms. Indeed, some of the insight into mechanisms regulating apoptosis has come from the examination of chemotherapyinduced death. It now appears that many inducers of cell death, ultimately converge on the activation of caspase-3(-like) proteases, which then appear to launch the terminal and execution stages of apoptosis (for review, see Ref. 5) . Although, some of the targeted proteins including poly(ADP-ribose) polymerase (PARP) (6) , gelsolin (7), DNA-dependent protein kinase (8) , D4-GDI (9), huntingtin (10) , PKC ␦ and (11, 12) , retinoblastoma protein (13) , PAK2 (14) , and ICAD (15, 16 ) may be death substrates, which upon cleavage, ensure apoptotic cell death, it remains unclear which substrates are responsible for the apoptotic cellular events.
Oxidative stress occurs in cells when there is an imbalance between the rate of generation of reactive oxygen species (ROS) and removal of ROS. Several lines of evidence support a role for ROS as a mediator of apoptosis. Hydrogen peroxide (H 2 O 2 ) treatment caused apoptosis in a variety of cell lines (17) (18) (19) . In addition, H 2 O 2 scavengers, such as N-acetyl-L-cysteine (NAC) and the reduced form of glutathione (GSH), could inhibit transforming growth factor ␤1-, tumor necrosis factor-␣-, and growth factor deprivation-induced apoptosis (17, 20 -22) . Furthermore, p53-mediated apoptosis was also inhibited by the treatment with diphenyleneiodonium chloride (DPI), an inhibitor of flavonoid-containing enzymes, such as NADPH oxidase and nitric oxide (NO) synthase (23) . Moreover, we reported that erbstatin-induced apoptosis was inhibited by NAC and GSH (24) , suggesting that ROS might play a critical role in apoptosis. Although the signaling pathway leading to ROS production has remained unclear, we previously reported that the generation of intracellular H 2 O 2 was modulated by the activation of caspase-3(-like) proteases during tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma (SCLC) cells (25) . Thus, we decided to ascertain whether generation of H 2 O 2 by caspase-3(-like) proteases was unique to tyrosine kinase inhibitor-induced apoptosis and to SCLC cells. In this report, we demonstrate that anticancer agents including camptothecin, vinblastine, inostamycin, and adriamycin induced caspase-3(-like) protease activation, H 2 O 2 production, and DNA fragmentation in both SCLC and leukemia cells. Furthermore, the drug-induced H 2 O 2 production was inhibited by the treatment with an inhibitor of caspase-3, thus suggesting that the production of H 2 O 2 is involved in anticancer drug-induced apoptosis via caspase-3(-like) protease activation.
EXPERIMENTAL PROCEDURES
Materials-Human SCLC cell line, Ms-1 cells (26) , and human T cell leukemia Jurkat cells were cultured in RPMI 1640 containing 5% fetal bovine serum, penicillin G (100 units/ml), and kanamycin (0.1 mg/ml) at 37°C in a 5% CO 2 , 95% air atmosphere. Camptothecin, adriamycin, and DPI were purchased from Sigma. Vinblastine sulfate was obtained from Wako Pure Chemical Industries, Ltd. (Tokyo, Japan). Inostamycin was isolated from Streptomyces as described previously (27) . DCFH-DA was obtained from Molecular Probes (Eugene, OR). Ac-YVAD-CHO and Ac-DEVD-CHO were purchased from Peptide Institute (Osaka, Japan).
Analysis of DNA Fragmentation-Drug-treated cells were washed and lysed in lysis buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 0.5% sodium N-lauroyl sarcosinate, and 100 g/ml proteinase K) for 5 h at 50°C. The lysates were extracted with phenol and chloroform, and the DNA in the aqueous layer was precipitated with ethanol following the addition of sodium acetate (final concentration of 0.3 M). The DNA was then collected by centrifugation and dried. The samples were finally dissolved in TE buffer (10 mM Tris-HCl, pH 8.0, and 1 mM EDTA), incubated at 37°C for 3 h with RNase A (1 g/ml), and electrophoresed on a 1.5% agarose gel.
Western Blotting-The cells were lysed in lysis buffer (25 mM HEPES, 1.5% Triton X-100, 0.1% SDS, 0.5 M NaCl, 5 mM EDTA, 0.1 mM sodium deoxycholate, 1 mM phenylmethylsulfonyl fluoride, and 0.1 mg/ml leupeptin, pH 7.8) at 4°C with sonication. The lysates were centrifuged at 15,000 ϫ g for 15 min, and the amount of protein in each lysate was measured by staining with Coomassie Brilliant Blue G-250. Loading buffer (42 mM Tris-HCl, pH 6.8, 10% glycerol, 2.3% SDS, 5% 2-mercaptoethanol, and 0.002% bromphenol blue) was then added to each lysate, which was subsequently boiled for 3 min and electrophoresed on an SDS-polyacrylamide gel. Proteins were transferred to Hybond-P membranes (Amersham Pharmacia Biotech) and immunoblotted with anti-PARP antibody (Santa Cruz Biotechnology, Santa Cruz, CA 3 H]thymidine for 24 h. The cells were washed once, treated with drugs for 1 h, and lysed with 1 ml of prewarmed (65°C) lysis solution (1.25% SDS, 5 mM EDTA, and 0.4 mg/ml salmon sperm DNA). After addition of prewarmed (37°C) 325 mM KCl solution, the lysates were immediately vortexed for 10 s. The samples were kept on ice for 30 min and then centrifuged. After the supernatants had been carefully removed, the pellets containing protein-DNA complexes were washed in 1 ml of ice-cold wash solution (10 mM TrisHCl, pH 7.5, 100 mM KCl, and 2 mM EDTA), and lysed. Radioactivities were counted in a liquid scintillation counter.
Tubulin Polymerization Assay-To measure the degree of tubulin polymerization, we used a modification of the method described by Scala et al. (30) . Ms-1 cells were treated with chemicals for 8 h. The cells were washed and lysed in hypotonic buffer (20 mM Tris-HCl, pH 6.8, 1 mM MgCl 2 , 2 mM EGTA, 0.5% Nonidet P-40, 2 mM phenylmethylsulfonyl fluoride, and 5 g/ml paclitaxel) at 37°C in the dark. Cell lysates were centrifuged at 14,000 rpm for 10 min at room temperature. Supernatants containing soluble (depolymerized) tubulin were carefully separated from the pellets containing polymerized tubulin. Western blot analysis for ␣-tubulin was performed.
Incorporation of 32 P i into Phospholipids-Ms-1 cells pretreated with NAC or Ac-DEVD-CHO were incubated with inostamycin in the presence of 32 P i (10 Ci/ml). After 3 h, the medium was removed and reaction was terminated by the addition of 10% trichloroacetic acid. The cells were scraped off and the lipids were extracted with CHCl 3 -MeOH. The lipid extracts labeled with 32 P i were spotted onto a silica gel thin-layer chromatogram, which was then developed with CHCl 3 -MeOH-acetic acid-H 2 O (25:15:4:2). Radioactive phosphatidylinositol (PI) was visualized by autoradiography, scraped off, and then counted in a liquid scintillation counter (31) .
RNA Synthesis-Ms-1 cells pretreated with NAC or Ac-DEVD-CHO were incubated with adriamycin in the presence of [ 3 H]uridine (1 Ci/ ml). After 1 h, the medium was removed and the cells were resuspended in 10% trichloroacetic acid. The radioactivity of the acid-insoluble fraction was counted in a liquid scintillation counter.
RESULTS

Anticancer Drugs Induce Production of H 2 O 2 during
Apoptosis in Ms-1 Cells-Exposure of Ms-1 cells to camptothecin, vinblastine, inostamycin, or adriamycin led to a dose-and time-dependent decrease in the number of viable cells, as determined by the trypan blue dye exclusion assay (Fig. 1A) . Moreover, DNA fragmentation was induced at 8 h after treatment with camptothecin (1 g/ml), inostamycin (0.3 g/ml), or adriamycin (3 g/ml), or at 24 h after treatment with vinblastine (0.1 g/ml) (Fig. 1B) . These results indicate that physiological concentrations of each drug induce apoptosis in Ms-1 cells. Next we tested the inhibitory effect of H 2 O 2 scavengers such as NAC and GSH on anticancer drug-induced apoptosis. As shown in Fig A, Ms-1 cells were pretreated with 100 M Ac-YVAD-CHO or 100 M Ac-DEVD-CHO for 2 h, and then the cells were treated with 1 g/ml camptothecin for 12 h, with 0.1 g/ml vinblastine for 24 h, with 0.3 g/ml inostamycin for 8 h, or with 3 g/ml adriamycin for 14 h. Cell viability was assessed by the trypan blue dye exclusion assay. Values are means Ϯ S.D. of quadruplicate determinations. B, Ms-1 cells were pretreated with 100 M Ac-DEVD-CHO for 2 h or with 20 mM NAC for 1 h, and then the cells were treated with 1 g/ml camptothecin, 0.1 g/ml vinblastine, 0.3 g/ml inostamycin, or 3 g/ml adriamycin for the indicated times. Twenty-microgram aliquots of cell lysates were immunoblotted with anti-PARP antibody.
into an 85-kDa COOH-terminal fragment and a 28-kDa NH 2 -terminal fragment. During anticancer drug-induced apoptosis, loss of the 116-kDa PARP was accompanied by the appearance of the 28-kDa polypeptide as demonstrated by Western blot analysis using an antibody directed against the NH 2 terminus (amino acids 1-20) of mouse PARP (Fig. 3B) . As expected, PARP cleavage by caspase-3 in cells treated with each anticancer drug was inhibited by Ac-DEVD-CHO. On the other hand, caspase-1 was not involved in apoptosis induced by the anticancer drugs we tested, because Ac-YVAD-CHO (100 M), an inhibitor of caspase-1 (33), failed to inhibit the anticancer druginduced apoptosis (Fig. 3A) .
Prevention of Anticancer Drug-induced Apoptosis by NAC or Ac-DEVD-CHO Is Not Due to the Inactivation of Each
Drug-To exclude the possibility that suppression of anticancer drug-induced apoptosis by NAC or Ac-DEVD-CHO was due to the inactivation or elimination of primary action of each anticancer drug, we examined the effects of NAC or Ac-DEVD-CHO on the inhibitory activity of anticancer drugs toward each cellular target: topoisomerase I for camptothecin, tubulin polymerization for vinblastine, PI synthesis for inostamycin, and RNA synthesis for adriamycin. As shown in Fig. 4A , camptothecin (1 g/ml)-induced stimulation of protein-DNA complex formation by inhibiting topoisomerase I was 10-fold even in the presence of NAC or Ac-DEVD-CHO, suggesting that NAC and Ac-DEVD-CHO did not affect the inhibitory activity of camptothecin against topoisomerase I. Vinblastine caused tubulin depolymerization, resulting in a shift in tubulin from the polymerized state found in the cell pellet to the unpolymerized state found in the cell supernatant. In the presence of NAC or Ac-DEVD-CHO, there was the same extent of vinblastine-induced tubulin depolymerization (Fig. 4B) . Moreover, NAC or Ac-DEVD-CHO affected neither inostamycin-inhibited PI synthesis nor adriamycin-inhibited RNA synthesis (Fig. 4, C and D) . Therefore, these results suggest that prevention of anticancer drug-induced apoptosis by NAC or Ac-DEVD-CHO was not due to the inactivation of the drugs. These results indicate that caspase-3(-like) proteases acted upstream of H 2 O 2 production in the pathway of anticancer drug-induced apoptosis. Indeed, as reported previously (25) , treatment with H 2 O 2 induced apoptosis, but not the activation of caspase-3(-like) proteases in Ms-1 cells. Additionally, NAC failed to inhibit caspase-3(-like) protease activation induced with camptothecin, vinblastine, and inostamycin, as assessed by PARP cleavage (Fig. 3B) . On the contrary, NAC inhibited adriamycin-induced caspase-3(-like) protease activation. Thus, it is suggested that ROS acted both upstream and downstream of caspase-3(-like) protease activation in adriamycin-induced apoptosis. Nevertheless, in general anticancer drug-induced apoptosis appears to require caspase-3(-like) protease activation, followed by H 2 O 2 production.
DPI Suppresses Anticancer Drug-induced Apoptosis and H 2 O 2 Generation-NADPH oxidase is known to catalyze the transfer of electrons from NADPH to O 2 , as summarized in the following reaction: NADPH ϩ 2O 2 
Ϫ is relatively short-lived and is rapidly converted to H 2 O 2 spontaneously or by superoxide dismutases. Therefore, we examined the possibility that anticancer drug-induced H 2 O 2 generation is mediated by NADPH oxidase by using DPI, which is known to inhibit NADPH oxidase. Pretreatment of Ms-1 cells with DPI (10 M) abolished the induction of apoptosis induced by each of the four anticancer drugs (Fig. 6A) . Moreover, anticancer drug-induced H 2 O 2 production was also suppressed by the treatment with DPI (Fig. 6B) . Because DPI is also known to inhibit NO synthase, we used N G -monomethyl-L-arginine (L-NMMA), a specific NO synthase inhibitor, to exclude the possibility that inhibition of anticancer drug-induced apoptosis by DPI was due to suppression of NO synthase rather than to that of NADPH oxidase. As shown in Fig. 6A , the data demonstrated that L-NMMA did not suppress any anticancer drug-induced apoptosis. Thus, NADPH oxidase appears to be involved in the induction of both anticancer drug-induced apoptosis and anticancer drug-induced H 2 O 2 generation.
H 2 O 2 Generation Mediated by Caspase-3(-like) Proteases Is Also Required for Apoptosis in Jurkat
Cells-To further investigate whether H 2 O 2 generation was modulated by caspase-3(-like) proteases in another cell line, we evaluated camptothecininduced apoptosis in human T cell leukemia Jurkat cells. Viability of Jurkat cells at 16 h following camptothecin (30 ng/ml) addition was 30% (Fig. 7A) . Pretreatment with Ac-DEVD-CHO (100 M), NAC (10 mM), or DPI (10 M) suppressed camptothecin-induced cell death in Jurkat cells (Fig. 7A) . Concomitant with the induction of DNA fragmentation, PARP was cleaved to the expected ϳ28-kDa fragment (Fig. 7, B and C) . Cleavage of PARP was eliminated by Ac-DEVD-CHO but not by NAC (Fig. 7C) . Furthermore, H 2 O 2 generation induced by camptothecin was inhibited by Ac-DEVD-CHO, NAC, or DPI in Jurkat cells (Fig. 7D) . Thus, H 2 O 2 generation mediated by caspase-3(-like) proteases, presumably through NADPH oxidase, is also required for camptothecin-induced apoptosis in Jurkat cells.
DISCUSSION
In the present study, we found that H 2 O 2 generation was a common event in the process of apoptosis induced by physiological concentrations of camptothecin, vinblastine, inostamycin, and adriamycin and that scavenging of H 2 O 2 production caused cells to fail to undergo apoptosis (Fig. 2, A and B) . These results suggest that the generation of H 2 O 2 is involved in apoptosis induced by various anticancer drugs irrespective of their mode of action. Furthermore, our findings demonstrate that anticancer drug-induced H 2 O 2 generation is a consequence of the activation of caspase-3(-like) proteases, which occurs independent of the cell type (Figs. 5 and 7D ). These observations are consistent with our previous findings that tyrosine kinase inhibitor-induced apoptosis required H 2 O 2 generation via caspase-3(-like) protease activation not only in Ms-1 cells but also in another SCLC line, Ms-13 cells, and in non-SCLC Ma-44 cells (24, 25) . These findings are also consistent with other findings. 1) ROS production was observed during Fas-mediated apoptosis, which production was eliminated by a caspase inhibitor (35) , and 2) activation of caspases and ROS production were sequential events in K ϩ deprivation-induced apoptosis of cerebellar granule neurons (36) . Taken together, the accumulated data reveal that H 2 O 2 generation appears to be one of critical events for apoptosis that occurs downstream of caspase-3(-like) protease activation in many types of cells.
We also found that inhibition of NADPH oxidase by DPI suppressed not only anticancer drug-induced apoptosis but also anticancer drug-induced H 2 O 2 production in both SCLC cells and leukemia cells (Figs. 6, A and B, and 7, A and D) . These results indicate that NADPH oxidase acts upstream of H 2 O 2 generation during anticancer drug-induced apoptosis. Furthermore, NADPH oxidase acts downstream of caspase-3 action, because DPI does not inhibit anticancer drug-induced caspase-3 activation as determined by the cleavage of PARP (data not shown). Our previous results indicated that activities of superoxide dismutase and catalase were not changed during tyrosine kinase inhibitor-induced apoptosis under the conditions where caspase-3(-like) proteases were activated and H 2 O 2 was produced (24, 25) . Thus, it is likely that anticancer druginduced generation of H 2 O 2 is mediated by NADPH oxidase, which is activated by caspase-3(-like) proteases.
How do caspase-3(-like) proteases activate NADPH oxidase? Although the targets for proteolytic cleavage by caspase-3(-like) proteases have been identified, the role of individual targets in mediating particular apoptotic events remains ill defined. Therefore, the precise mechanism of NADPH oxidase activation mediated by caspase-3(-like) proteases is not fully understood at present. Nevertheless, two possible mechanisms have been proposed. NADPH oxidase is a highly regulated membrane-bound enzyme complex that is composed of a number of cytosolic and membrane-bound proteins (37) . Translocation is initiated by a series of highly regulated signaling events, including phosphorylation of one or more of the NADPH oxidase protein components, resulting in assembly of the active complex. Activated Rac (GTP-bound form) is an indispensable component of NADPH oxidase activation. In cells, Rac is complexed with a guanosine nucleotide exchange factor known as Rho GDP-dissociation inhibitor (Rho GDI), and it has been suggested that Rho GDI functions in part to keep Rac in a soluble, GDP-bound form. Rac dissociates from Rho GDI, and Rac subsequently translocates to the plasma membrane, thereby enhancing the activity of the NADPH oxidase. Recent studies of a direct link between Rho GDI and caspase-3 provides a possible clue. D4-GDI, a hematopoietic Rho GDI, is a substrate of caspase-3 and is cleaved during apoptosis in Jurkat cells (9) . In addition, caspase inhibitors abrogate coordinately D4-GDI cleavage and apoptosis (9) . These findings indicate that the activation of caspase-3(-like) proteases cleaves Rho GDI, leading to Rac activation during apoptosis, thereby allowing NADPH oxidase activation in hematopoietic cells. Indeed, transgenic mice that express constitutively activated forms of Rac2 showed enhanced apoptosis in their thymus (38) . Moreover, recent results indicated that ROS generation might be regulated by Rac in fibroblasts (39) and T cell lines (40) . Therefore, Rac-dependent pathways seem likely to be involved in caspase-3(-like) protease-mediated activation of NADPH oxidase during apoptosis induced by anticancer drugs. Another possibility is the involvement of protein kinases in caspasemediated NADPH oxidase activation. PKC ␦ and and PAK2 are known to be cleaved and activated by caspases during apoptosis (11, 12, 14) , and to be able to phosphorylate p47 phox (14, (41) (42) (43) (44) . Because phosphorylated p47
phox is absolutely required for NADPH oxidase activity, it is likely that anticancer drug-induced caspase activation results in cleavage and activation of PKC ␦, PKC , or PAK2, which then phosphorylates p47 phox , which in turn activates NADPH oxidase. The biochemical mechanism underlying H 2 O 2 -mediated apoptosis following the treatment with various anticancer drugs remains to be elucidated. Recently, caspase-activated DNase and its inhibitor, CAD and ICAD, respectively, were cloned by Nagata et al. (15, 16) . CAD and ICAD are expressed ubiquitously in various tissues, and CAD contains a nuclear-localization signal (15, 16) . Active caspase-3 can cleave ICAD, which probably releases CAD from ICAD. Thus, CAD translocates to nucleus and hydrolyzes nuclear DNA. This mechanism is very similar to that used by the NF-B system (45, 46) ; NF-B is kept as a complex with IB in the cytoplasm until various stimuli activate a kinase cascade that leads to the ubiquitindependent degradation of IB. The degraded IB dissociates from NF-B, and the latter then enters the nucleus to activate or repress the expression of various genes. Interestingly, previous studies have suggested that the activation of NF-B may be redox-dependent (47-51). In particular, exogenous H 2 O 2 stimulates NF-B, whereas chemical antioxidants inhibit the activation of NF-B by a variety of exogenous stimuli. Taken together with the similarity of the activation mechanism between NF-B and CAD, although we do not have any evidence that CAD activation is redox-dependent, it is possible that H 2 O 2 generated by caspase-3(-like) protease activation participates, at least in part, in the full activation and/or translocation to the nucleus of CAD released by caspase-3-mediated degradation of ICAD. However, apoptosis could be induced under very low oxygen conditions (52, 53) . Further studies are necessary to determine whether caspases are activated under hypoxia conditions. Anthracyclines, such as adriamycin and daunomycin, are one of the most active antitumor agents used in clinical oncology. It has been documented that anthracyclines induce membrane alterations through lipid peroxidation; generate ROS due to electron transfer from the semiquinone ring; intercalate into nuclear DNA, in turn inhibiting macromolecular synthesis; and interact with topoisomerase II, leading to covalent binding of these enzymes to DNA and subsequent DNA breaks (54) . Therefore, it is difficult to define which mechanism induced by adriamycin is responsible for apoptosis. In the present study, we show that NAC inhibited the adriamycin-induced caspase-3(-like) protease activation, but not adriamycin-induced RNA synthesis inhibition (Figs. 3B and 4D) . Furthermore, Ms-1 cells are relatively resistant to etoposide, an inhibitor of topoisomerase II (data not shown), possibly due to decreased expression of topoisomerase II, as seen in many etoposide-resistant SCLC cells (55) , suggesting that adriamycin-induced apoptosis may not be due to the inhibition of topoisomerase II. Taken together, it seems that ROS generation rather than the inhibition of topoisomerase II or RNA synthesis is responsible for the adriamycin-induced activation of caspase-3(-like) proteases.
In summary, although the mechanisms for the activation of caspase-3(-like) proteases would depend on each drug, NADPH oxidase activation and subsequent H 2 O 2 generation appear to be a common apoptotic pathway downstream of caspase-3(-like) proteases. Furthermore, H 2 O 2 may serve as a major mediator for anticancer drug-induced apoptosis in several types of cells.
